When was DexCare founded?

DexCare was founded in 2021 and raised its 1st funding round within a year of its incorporation.

Where is DexCare located?

DexCare is headquartered in Seattle, United States. It is registered at 427 Broadway,New York, NY 10013.

How many employees does DexCare have?

As of Apr 30, 2026, the latest employee count at DexCare is 136.

Is DexCare a funded company?

DexCare is a funded company, having raised a total of $192M across 5 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Mar 10, 2021.

When was the latest funding round of DexCare?

DexCare's latest funding was a $***** Series C round on Jun 12, 2024, with participation from 4 investors. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $3.19B in funding in 2026 to date.

Where does DexCare rank among its competitors?

DexCare ranks 10th amongst 292 active competitors, of which 43 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Hublo, which secured $47.3M in Feb, 2026.

Who are the top competitors of DexCare?

DexCare's top competitors include IQVIA, Hublo and AVIA. Among them, Hublo secured the most recent funding round in February, 2026.

DexCare - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of data-driven business intelligence platform for healthcare organizations. It offers a platform that helps patients to get the right care setting, generate new patients, increase revenue, better satisfaction, and substantial cost saving for both patients and providers.

Website: dexcare.com
Social
Email ID: *****@dexcarehealth.com
Registered Address: 427 Broadway,New York, NY 10013

Key Metrics

Founded Year

2021

Location

Seattle, United States

Stage

Series C

Total Funding

$192M in 5 rounds

Latest Funding Round

Series C, Jun 12, 2024, $*****

Investors

Iconiq Capital & 12 more

Ranked

10^th among 292 active competitors

Employee Count

136 as on Apr 30, 2026

Investment & Acquisitions

Womp & 1 more

Similar Companies

IQVIA & 410 more

View DexCare's full profile

DexCare is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Dexcare, Inc. CIN: 861224905 , United States, Active		-	168 (As on Dec 31, 2024)	-
DEXCARE, INC. CIN: 86-1224905 , United States, Active	Dec 22, 2020	-	30 (As on Dec 31, 2021)	-

DexCare has raised a total funding of $192M over 5 rounds. Its first funding round was on Mar 10, 2021. Its latest funding round was a Series C round on Jun 12, 2024 for $*****. 4 investors participated in its latest round. DexCare has 13 institutional investors.

Here is the list of recent funding rounds of DexCare:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 12, 2024	4496428	Series C	9423788	2746578	8813648	3627665
Jun 26, 2023	2635959	Series C	4424739	9612052	6809979	9137073
May 21, 2023	9019716	Series C	5193657	5050824	Iconiq Capital	Transformation Capital & 4 more

Access funding benchmarks and valuations. Sign up today!

View details of DexCare's funding rounds and investors

The founders of DexCare is Sean OConnor.

Here are the details of DexCare's key team members:

Sean OConnor: Co-Founder & CSO of DexCare.

DexCare's Board of Directors

DexCare's board has 8 active members. Todd Cozzens, Derek Streat, Aaron Martin, Caroline Xie, Lynne Chou O'Keefe, Lynne Chou O?Keefe, David Kereiakes and Delos Cosgrove are independent board members.

Here is the list of DexCare's board of directors:

Name	Type	Representing	Status	Duration
Todd Cozzens	Independent board member	-	Current	2y 10m
cjtufse	Independent board member	-	Current	7y 1m
vtvcptg	Independent board member	-	Current	1y 7m
mlehdrt	Independent board member	-	Current	6y 8m
wcluitp	Independent board member	-	Current	1y 2m
yw{pcun	Independent board member	-	Current	5y 6m
divznrd	Independent board member	-	Current	9y 9m
f{ivred	Independent board member	-	Current	4y 5m

View details of DexCare's Founder profiles and Board Members

DexCare's employee count trend

DexCare has 136 employees as of Apr 26. Here is DexCare's employee count trend over the years:

Uncover DexCare's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of DexCare include IQVIA, Hublo and AVIA. Here is the list of Top 10 competitors of DexCare, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	IQVIA 1982, Durham (United States), Public	Provider of clinical research and commercialization solutions for healthcare	$1.74M	Leonard Green and Partners, Fisher Lynch Capital ... & 11 others	80/100
2nd	Hublo 2013, Montreuil (France), Series C	Platform for hospitals to manage staff recruitments and replacements	$74.6M	Acton Capital, Y Combinator & 4 others	72/100
3rd	AVIA 2003, Chicago (United States), Series B	Digital business management and networking platform for the healthcare industry	$50M	Providence Health & Services, MemorialCare Innovation Fund ... & 20 others	68/100
4th	Saama 1999, Campbell (United States), Series C	AI-enabled platofrm for clinical trial data analytics	$75.8M	Merck Global Health Innovation Fund, Pfizer ... & 9 others	64/100
5th	Advisory 1979, Washington, DC (United States), Public	Healthcare insights, research, and expert guidance for industry leaders	-	Oxeon Partners	64/100
6th	VisiQuate 2009, Santa Rosa (United States), Acquired	AI-based data analytics and visualization for healthcare	$70.2M	First Analysis, Sixth Street & 5 others	61/100
7th	Dental Intel 2012, Provo (United States), Series A	Dental Intelligence: End-to-end practice performance solution, actionable insights, automation	$34M	PSG, Blue Star Innovation Partners & 1 others	61/100
8th	Sikka Technologies 2004, San Jose (United States), Series C	AI and cloud-based business managemnt tool for healthcare professionals	$18.8M	Sierra Ventures, Orbimed & 2 others	60/100
9th	Claritas Rx 2011, San Francisco (United States), Series A	Data integration and business analytics company for pharmaceutical manufacturers	$19.1M	Questa Capital, Kiplin Capital	59/100
10th	DexCare 2021, Seattle (United States), Series C	Provider of data-driven business intelligence platform for healthcare organizations	$192M	Kaiser Permanente Ventures, Allumia Ventures ... & 11 others	59/100